How newer drugs are sequenced with older ones

Metastatic breast cancer is usually treated with one treatment at a time, moving to the next when the current one stops working or causes too many side effects. The order, called sequencing, depends mainly on the cancer's receptors, HER2 status and gene test results, what treatments have already been used, how quickly the cancer is growing, and your health and preferences. For hormone receptor positive, HER2-negative cancer, a CDK4/6 inhibitor with hormone therapy usually comes first. Later options are chosen using mutation tests, such as alpelisib for PIK3CA, an oral SERD for ESR1, or olaparib for BRCA, before moving to antibody-drug conjugates and chemotherapy.

Why the order matters

Using the most effective, best-tolerated treatments first often keeps the cancer controlled for longest while preserving quality of life. Some drugs are only proven after others have been used.

Why testing shapes the sequence

Mutations can open up targeted options, and some develop only after earlier treatment. Repeat testing at progression helps choose the best next step.

When the usual order changes

If the cancer is growing rapidly, affecting organ function, or causing serious symptoms, chemotherapy may be used earlier because it tends to work faster.

The best order for many newer drugs is still being studied. Much of the evidence comes from trials that compared a drug with an older standard, rather than comparing all the new options against each other. Oncologists therefore combine trial evidence, guidelines and experience.

Each line tends to work for less time

Later treatments usually control the cancer for shorter periods than earlier ones, although individual responses vary and some people do very well on later lines.

Access shapes real-world sequences

In India, availability and cost can affect which drugs are used and when. A realistic plan uses the most effective options that are accessible.

Your priorities matter

Side effects, hospital visits and quality of life are part of choosing the next treatment, alongside effectiveness.

What this page cannot tell you

It cannot tell you the right order for you. Ask your oncologist how they are planning your sequence and why.

Each change of treatment is a good time to review the overall plan with your oncologist.

About the next treatment

Ask why this drug has been chosen now, what it aims to achieve, how it is given and what side effects to expect.

About the options after it

Ask what could come next if this treatment stops working, and whether any tests should be done now to prepare.

About trials and cost

Ask whether a clinical trial might suit you and what support is available for the cost of the proposed drug.

Planning treatment for metastatic breast cancer is often a team effort.

Tumour boards

Medical oncologists, radiologists, pathologists, radiation oncologists and surgeons may review complex cases together to agree the best plan.

Your voice in the plan

Share what matters most to you, such as time at home, work, travel or avoiding particular side effects, so the team can shape the sequence around your life as well as your cancer.

Local treatments alongside

Radiation or surgery may be used for specific areas, such as painful bone metastases, alongside the main drug sequence.

Keeping a treatment record

A simple written list of every treatment you have had, when it started and stopped, and why it was changed, is very helpful. It makes second opinions, trial screening and future decisions faster and more accurate, especially if you are seen at more than one hospital.

Palliative care from the start

Specialist symptom control supports quality of life throughout, not only at the end.